{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:34:10Z","timestamp":1792632850823,"version":"4.5.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.humpath.2024.105671","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T05:48:14Z","timestamp":1729144094000},"page":"105671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Systemic ALK-negative anaplastic large cell lymphoma: Insights into morphologic, immunophenotypic, genetic and molecular characteristics"],"prefix":"10.1016","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1815-7666","authenticated-orcid":false,"given":"Wei","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1897-1644","authenticated-orcid":false,"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2024.105671_bib1","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib2","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.105671_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/PAP.0000000000000047","article-title":"Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous","volume":"22","author":"Xing","year":"2015","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib4","doi-asserted-by":"crossref","first-page":"18525","DOI":"10.18632\/oncotarget.14503","article-title":"The heterogeneous landscape of ALK negative ALCL","volume":"8","author":"Mereu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2024.105671_bib5","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2024.105671_bib6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1182\/bloodadvances.2020001581","article-title":"ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project","volume":"5","author":"Shustov","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2024.105671_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13184667","article-title":"ALK-negative anaplastic large cell lymphoma: current concepts and molecular pathogenesis of a heterogeneous group of large T-cell lymphomas","volume":"13","author":"Pina-Oviedo","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.humpath.2024.105671_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.semdp.2019.12.002","article-title":"Pathology and genetics of anaplastic large cell lymphoma","volume":"37","author":"Leventaki","year":"2020","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib9","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1167\/iovs.12-9798","article-title":"A randomized, controlled trial of an intervention promoting cataract surgery acceptance in rural China: the Guangzhou Uptake of Surgery Trial (GUSTO)","volume":"53","author":"Liu","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.humpath.2024.105671_bib10","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1365-2141.2001.02896.x","article-title":"Anaplastic large cell lymphoma: pathological, molecular and clinical features","volume":"114","author":"Falini","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2024.105671_bib12","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1182\/blood-2010-02-270785","article-title":"Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group","volume":"116","author":"Schmitz","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib13","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1200\/JCO.2012.42.2345","article-title":"Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials","volume":"30","author":"Sibon","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2024.105671_bib14","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib15","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2014-04-573089","article-title":"Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry","volume":"124","author":"Ellin","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib16","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2015.63.5540","article-title":"Racial patterns of peripheral T-cell lymphoma incidence and survival in the United States","volume":"34","author":"Adams","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2024.105671_bib17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.critrevonc.2012.06.004","article-title":"Anaplastic large cell lymphoma, ALK-negative","volume":"85","author":"Ferreri","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.humpath.2024.105671_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13246316","article-title":"The leukemic phase of ALK-negative anaplastic large cell lymphoma is associated with CD7 positivity, complex karyotype, TP53 deletion, and a poor prognosis","volume":"13","author":"Qiu","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.humpath.2024.105671_bib19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1440-1789.2008.00935.x","article-title":"Primary ALK-1-negative anaplastic large cell lymphoma of the brain: case report and review of the literature","volume":"29","author":"Kodama","year":"2009","journal-title":"Neuropathology"},{"key":"10.1016\/j.humpath.2024.105671_bib20","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/modpathol.2012.38","article-title":"Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders","volume":"25","author":"Sciallis","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.oooo.2013.10.002","article-title":"The spectrum of primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck","volume":"117","author":"Wang","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.humpath.2024.105671_bib22","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1038\/leu.2009.161","article-title":"Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma","volume":"23","author":"Eckerle","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.105671_bib23","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","article-title":"CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features","volume":"96","author":"Stein","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.celrep.2016.09.018","article-title":"Insights into the pathogenesis of anaplastic large-cell lymphoma through genome-wide DNA methylation profiling","volume":"17","author":"Hassler","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.humpath.2024.105671_bib25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1309\/R2Q9CCUVTLRYCF3H","article-title":"Anaplastic large cell lymphoma","volume":"127","author":"Medeiros","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib26","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3324\/haematol.2022.281222","article-title":"DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma","volume":"108","author":"Qiu","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2024.105671_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAS.0000000000000500","article-title":"Morphologic features of ALK-negative anaplastic large cell lymphomas with DUSP22 rearrangements","volume":"40","author":"King","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib28","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/PAS.0000000000001708","article-title":"JAK2 rearrangements are a recurrent alteration in CD30+ systemic T-cell lymphomas with anaplastic morphology","volume":"45","author":"Fitzpatrick","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1182\/blood-2014-12-614503","article-title":"Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts","volume":"127","author":"Scarfo","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib30","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/bjh.12777","article-title":"Paediatric anaplastic large cell lymphoma with leukaemic presentation in children: a report of nine French cases","volume":"165","author":"Spiegel","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2024.105671_bib31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1440-1827.2009.02376.x","article-title":"Anaplastic large cell lymphoma in leukemic phase: extraordinarily high white blood cell count","volume":"59","author":"Nguyen","year":"2009","journal-title":"Pathol Int"},{"key":"10.1016\/j.humpath.2024.105671_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajh.20758","article-title":"Pediatric ALK+ anaplastic large cell lymphoma with t(3;8)(q26.2;q24) translocation and c-myc rearrangement terminating in a leukemic phase","volume":"82","author":"Monaco","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2024.105671_bib33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00277-007-0289-3","article-title":"Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature","volume":"86","author":"Grewal","year":"2007","journal-title":"Ann Hematol"},{"key":"10.1016\/j.humpath.2024.105671_bib34","first-page":"2993","article-title":"Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T\/null cell phenotype","volume":"96","author":"Suzuki","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5858\/133.1.49","article-title":"Flow cytometric immunophenotyping of anaplastic large cell lymphoma","volume":"133","author":"Muzzafar","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2024.105671_bib36","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/PAS.0000000000000188","article-title":"Diagnostic accuracy of a defined immunophenotypic and molecular genetic approach for peripheral T\/NK-cell lymphomas. A North American PTCL study group project","volume":"38","author":"Hsi","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib37","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1200\/JCO.2012.46.7910","article-title":"Anaplastic large-cell lymphoma with aberrant expression of multiple cytokeratins masquerading as metastatic carcinoma of unknown primary","volume":"31","author":"Nguyen","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2024.105671_bib38","first-page":"798","article-title":"Cytokeratin positivity in anaplastic large cell lymphoma: a potential diagnostic pitfall in misdiagnosis of metastatic carcinoma","volume":"6","author":"Zhang","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/ajcp\/aqab012","article-title":"How I diagnose anaplastic large cell lymphoma","volume":"155","author":"Amador","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib40","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/01.MP.0000036386.87517.AA","article-title":"Clusterin expression in malignant lymphomas: a survey of 266 cases","volume":"15","author":"Saffer","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib41","first-page":"3692","article-title":"Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma","volume":"9","author":"Khoury","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2024.105671_bib42","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41379-019-0336-3","article-title":"PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma","volume":"33","author":"Shen","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9440(10)61724-5","article-title":"Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T\/null-cell lineage","volume":"159","author":"Rassidakis","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib44","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.humpath.2003.10.013","article-title":"Absence of Epstein-Barr virus in anaplastic large cell lymphoma: a study of 64 cases classified according to World Health Organization criteria","volume":"35","author":"Herling","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib45","first-page":"100","article-title":"Epstein-Barr virus positive anaplastic large cell lymphoma: myth or reality?","volume":"4","author":"Ma","year":"2010","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib46","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00000478-200403000-00018","article-title":"Anaplastic large cell lymphoma associated with Epstein-Barr virus following cardiac transplant","volume":"28","author":"Pitman","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib47","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0046-8177(99)90281-2","article-title":"The expression of TIA-1+ cytolytic-type granules and other cytolytic lymphocyte-associated markers in CD30+ anaplastic large cell lymphomas (ALCL): correlation with morphology, immunophenotype, ultrastructure, and clinical features","volume":"30","author":"Felgar","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib48","first-page":"319","article-title":"CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis","volume":"22","author":"Gorczyca","year":"2003","journal-title":"Int J Oncol"},{"key":"10.1016\/j.humpath.2024.105671_bib49","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1309\/PLN1NA4QB2PC1CMQ","article-title":"The expression of myeloid antigens CD13 and\/or CD33 is a marker of ALK+ anaplastic large cell lymphomas","volume":"130","author":"Bovio","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib50","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1182\/blood-2017-12-819987","article-title":"An anaplastic T-cell lymphoma mimicking classical Hodgkin lymphoma","volume":"131","author":"Wang","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib51","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/modpathol.2010.4","article-title":"PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus","volume":"23","author":"Feldman","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib52","doi-asserted-by":"crossref","first-page":"E395","DOI":"10.1002\/dc.24821","article-title":"ALK-negative anaplastic large cell lymphoma, null type with aberrant expression of PAX5 and CD138: a diagnostic pitfall","volume":"49","author":"Salyana","year":"2021","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.humpath.2024.105671_bib53","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.3324\/haematol.2018.205880","article-title":"DUSP22-rearranged anaplastic lymphomas are characterized by specific morphological features and a lack of cytotoxic and JAK\/STAT surrogate markers","volume":"104","author":"Onaindia","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2024.105671_bib54","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood-2016-12-755496","article-title":"DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study","volume":"130","author":"Pedersen","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib55","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1111\/bjh.15860","article-title":"Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma","volume":"186","author":"Hapgood","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2024.105671_bib56","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1182\/blood.2019004164","article-title":"\"Double-hit\" of DUSP22 and TP63 rearrangements in anaplastic large cell lymphoma, ALK-negative","volume":"135","author":"Karube","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib57","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3324\/haematol.2022.281442","article-title":"ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study","volume":"108","author":"Sibon","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2024.105671_bib58","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/leu.2017.309","article-title":"Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma","volume":"32","author":"Hu","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.105671_bib59","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1111\/bjh.17169","article-title":"Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with MYC rearrangement","volume":"192","author":"Khanlari","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2024.105671_bib60","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2024.105671_bib61","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood-2018-03-838524","article-title":"Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements","volume":"132","author":"Luchtel","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib62","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/PAS.0000000000001614","article-title":"Striking association of lymphoid enhancing factor (LEF1) overexpression and DUSP22 rearrangements in anaplastic large cell lymphoma","volume":"45","author":"Ravindran","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib63","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1038\/ncomms4618","article-title":"The phosphatase JKAP\/DUSP22 inhibits T-cell receptor signalling and autoimmunity by inactivating Lck","volume":"5","author":"Li","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2024.105671_bib64","doi-asserted-by":"crossref","first-page":"68734","DOI":"10.18632\/oncotarget.11930","article-title":"Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes","volume":"7","author":"Melard","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2024.105671_bib65","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","article-title":"Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing","volume":"117","author":"Feldman","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/10428194.2015.1064530","article-title":"Genetics of anaplastic large cell lymphoma","volume":"57","author":"Zeng","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2024.105671_bib67","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas","volume":"120","author":"Vasmatzis","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib68","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/blood-2016-06-722645","article-title":"Somatic JAK2 mutations and their tumor phenotypes","volume":"128","author":"Tefferi","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib69","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2012.03.017","article-title":"Janus kinase deregulation in leukemia and lymphoma","volume":"36","author":"Chen","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.humpath.2024.105671_bib70","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10555-016-9623-3","article-title":"Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology","volume":"35","author":"Goel","year":"2016","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.humpath.2024.105671_bib71","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.humpath.2020.11.002","article-title":"MYC expression is associated with older age, common morphology, increased MYC copy number, and poorer prognosis in patients with ALK+ anaplastic large cell lymphoma","volume":"108","author":"Lyapichev","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib72","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1158\/0008-5472.CAN-07-6398","article-title":"Novel and highly recurrent chromosomal alterations in Sezary syndrome","volume":"68","author":"Vermeer","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2024.105671_bib73","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/gcc.20386","article-title":"Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: a matrix-based CGH approach","volume":"46","author":"Thorns","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2024.105671_bib74","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2014-07-588434","article-title":"A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders","volume":"124","author":"Velusamy","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib75","series-title":"Systemic ALK-negative anaplastic large cell lymphoma with NPM1::TYK2 rearrangement","author":"Johnson","year":"2024"},{"key":"10.1016\/j.humpath.2024.105671_bib76","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1182\/blood-2013-04-497933","article-title":"PRDM1\/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma","volume":"122","author":"Boi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib77","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.onc.1205152","article-title":"Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death","volume":"21","author":"Zamo","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2024.105671_bib78","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm1249","article-title":"Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target","volume":"11","author":"Chiarle","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.humpath.2024.105671_bib79","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41375-020-01093-1","article-title":"STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma","volume":"35","author":"Lobello","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.105671_bib80","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/sj.leu.2403840","article-title":"p53 gene mutations are uncommon but p53 is commonly expressed in anaplastic large-cell lymphoma","volume":"19","author":"Rassidakis","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.105671_bib81","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.20110283","article-title":"Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas","volume":"208","author":"Pilati","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.humpath.2024.105671_bib82","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1182\/blood-2013-04-494930","article-title":"STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients","volume":"122","author":"Jerez","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib83","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1182\/blood.2019000626","article-title":"Recurrent MSC (E116K) mutations in ALK-negative anaplastic large cell lymphoma","volume":"133","author":"Luchtel","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib84","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2008.20.9759","article-title":"Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms","volume":"28","author":"Piva","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2024.105671_bib85","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.humpath.2005.03.004","article-title":"Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas","volume":"36","author":"Thompson","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib86","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Lymphoma Leukemia Molecular Profiling P, the International Peripheral TcLP. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib87","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/blood-2006-06-028969","article-title":"Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes","volume":"109","author":"Lamant","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib88","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1182\/blood-2012-01-405555","article-title":"Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma","volume":"120","author":"Agnelli","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib89","first-page":"1235","article-title":"Localization of the human HER4\/erbB-4 gene to chromosome 2","volume":"10","author":"Zimonjic","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2024.105671_bib90","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.4161\/cc.10.16.17194","article-title":"Function of ERBB4 is determined by alternative splicing","volume":"10","author":"Veikkolainen","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.humpath.2024.105671_bib91","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrc3309","article-title":"The ERBB network: at last, cancer therapy meets systems biology","volume":"12","author":"Yarden","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2024.105671_bib92","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.3324\/haematol.2013.084913","article-title":"CD30 expression in peripheral T-cell lymphomas","volume":"98","author":"Sabattini","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2024.105671_bib93","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3324\/haematol.2012.081935","article-title":"CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features","volume":"98","author":"Bisig","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2024.105671_bib94","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41568-020-0247-0","article-title":"Peripheral T cell lymphomas: from the bench to the clinic","volume":"20","author":"Fiore","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2024.105671_bib95","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/leu.2008.320","article-title":"Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas","volume":"23","author":"Feldman","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.105671_bib96","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/modpathol.3800473","article-title":"Rare expression of T-cell markers in classical Hodgkin's lymphoma","volume":"18","author":"Tzankov","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2024.105671_bib97","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1182\/blood-2004-03-1037","article-title":"Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling","volume":"104","author":"Bonzheim","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib98","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1182\/blood.V95.10.3020","article-title":"Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease","volume":"95","author":"Seitz","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105671_bib99","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.5858\/2006-130-1772-GRACGH","article-title":"Gene rearrangement and comparative genomic hybridization studies of classic Hodgkin lymphoma expressing T-cell antigens","volume":"130","author":"Aguilera","year":"2006","journal-title":"Arch Pathol Lab Med"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724001801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724001801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T21:41:35Z","timestamp":1741297295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817724001801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":99,"alternative-id":["S0046817724001801"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2024.105671","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic ALK-negative anaplastic large cell lymphoma: Insights into morphologic, immunophenotypic, genetic and molecular characteristics","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2024.105671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105671"}}